Attralus Therapeutics
Dr. Maurer is Professor of Cardiology at Columbia University, College of Physicians and Surgeons, where he directs the Clinical Cardiovascular Research Laboratory at the Allen Hospital of New York Presbyterian Hospital. He is a world-renowned expert in cardiac amyloidosis. He has published over 200 articles and was co-chair of the Steering Committee of the ATTR ACT trial (pivotal trial for tafamidis).
This person is not in the org chart
This person is not in any offices
Attralus Therapeutics
Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.